BLOG

Biopharmaceutical companies developing new CNS products can face special obstacles. According to an article published on...

IBS is the name doctors have given to conditions characterized by cramp like abdominal pains, bloating and bouts of diarrhea and/or constipation. According to an article in Nature, it affects...

“Patient centricity” is the process of designing a service or solution around the patient; more specifically, it is collectively defined as “Putting the patient first in...

There is a lot (A LOT) of information on the internet about clinical trials. What exactly are clinical trials? What are the different phases? What does each phase test? How safe are they? An...

What are biosimilars, and what does the future hold in store for them?

In June 2016, the National Institutes of Health (NIH) released a new policy on the use of a single i...

It’s the much-anticipated Part II of our “What Does it Take” series (insert glorious trumpet announcement sound here). In Part I, we discussed general First-In-Human (FIH) clinical trials, and...